Portfolio Update

BLACKROCK INCOME AND GROWTH INVESTMENT TRUST PLC All information is at 28 June 2013 and unaudited. Performance at month end with net income reinvested One Three One Since Three Five month months year 1 April years years 2012 Sterling: Share price -5.2% -1.0% 23.3% 21.4% 38.6% 17.2% Net asset value -4.8% -2.1% 13.5% 11.8% 37.2% 13.2% FSTE All-Share Total Return -5.0% -1.7% 17.9% 14.8% 43.5% 38.2% Sources: BlackRock and Datastream BlackRock took over the investment management of the Company with effect from 1 April 2012. At month end Sterling: Net asset value - capital only: 150.25p Net asset value - cum income*: 154.49p Share price: 153.50p Total assets (including income): £42.8m Discount to cum-income NAV: 0.6% Gearing: 4.0% Net yield**: 3.4% Ordinary shares in issue***: 27,729,268 Gearing range (as a % of net assets) 0-20% * includes net revenue of 4.24 pence per share ** based on final dividend of 3.45p per share in respect of the year ended 31 October 2012 and an interim dividend of 1.80p per share in respect of the year ended 31 October 2012. *** excludes 5,204,664 shares held in treasury Benchmark Sector Analysis Total assets( %) Oil & Gas Producers 12.7 Banks 12.3 Pharmaceuticals & Biotechnology 10.0 Tobacco 9.7 Food Producers 5.7 Mobile Telecommunications 5.3 Travel & Leisure 4.9 Mining 4.9 Non- Life Insurance 4.7 Life Insurance 4.0 Financial Services 3.8 Support Services 3.4 Media 2.8 Gas, Water & Multiutilities 2.3 General Retailers 2.3 Real Estate Investment & services 2.1 Electronic & Electrical Equipment 2.1 Industrial Engineering 1.5 Oil Equipment, Services & Distribution 1.4 Fixed Line Telecommunications 1.4 Household Goods & Home Construction 1.1 General Industrials 1.0 Non-Equity Investment Instruments 0.7 Net Current Liabilities (0.1) ------- Total 100.00 ------- Ten Largest Equity Investments Company % of Total assets HSBC 7.1 Royal Dutch Shell B 7.0 British American Tobacco 6.2 GlaxoSmithKline 5.9 Vodafone 5.5 Imperial Tobacco 4.0 Barclays 3.6 Shire 3.4 Unilever 3.1 Admiral 3.0 Commenting on the markets, Adam Avigdori, representing the Investment Manager noted: Markets With economic news improving in most of the developed world, many of the major equity markets have marched steadily upwards over the past year, helped by the actions taken by central banks around the world to boost the global economy. At the end of May, however, most global markets were impacted by a statement from the US Federal Reserve that laid out a timetable for withdrawing its quantitative easing programme earlier than had been anticipated which sent equity, bond and commodity markets lower worldwide. The FTSE All-Share Index saw its first monthly fall in a year in June, down by 5.0% for the month and down by almost 2.0% during the second quarter. Miners were the most negative contributors to overall index performance in the second quarter, after an equally poor contribution during the first quarter. Companies with more defensive earnings, such as pharmaceuticals and telecoms, were positive contributors to market returns in the second quarter. Portfolio Performance The portfolio returned -4.8% in June, slightly ahead of the FTSE All-Share Index return of -5.0%. The positive contributors included Tate & Lyle, the supplier of speciality ingredients to the food and beverages industries, which has benefited from the market's re-appraisal of its new management team and strategy, reporting good results and profit growth. Carphone Warehouse was a positive contributor to relative returns after announcing the buyout of its joint venture partner Best Buy and stronger than expected revenues from its UK operations. Best Buy originally purchased 50% of Carphone Warehouse Europe in a joint venture for $2.1bn in 2008, and at the end of June Carphone Warehouse Group bought out its JV partner for $775 million as Best Buy refocuses on its US business. We purchased a new holding in Partnership Assurance in the IPO as we believe the company will demonstrate above market earnings growth and the shares outperformed following the IPO, which was priced on a market rating. This company is a specialist insurer that provides financial products to people with a wide variety of health conditions that are likely to reduce their life expectancy. The largest detractor from performance was the holding in Oxford Instruments, the provider of high technology tools and systems for research and industry. The shares were down in June after the company highlighted some weakness in end markets when announcing its full year results. We took the opportunity of the share price weakness to add to the position. Copper miner Antofagasta detracted from returns, but having an underweight position in BHP Billiton and not owning Anglo American, Rio Tinto and Glencore Xstrata were all positive for relative returns. Overall, the portfolio's underweight exposure to mining was positive for relative performance as the sector continued to suffer from demand concerns and commodity price weakness. We sold the portfolio's holdings of Diageo and Prudential and initiated new positions in Unilever and Partnership Assurance Group. We reduced the holdings of HSBC and UBM and added to the Reed Elsevier position. Outlook Global GDP growth forecasts remain positive but are still being revised downwards, in part due to the slowing growth of the emerging economies and China in particular. UK equity valuations still look attractive compared to those of most other asset classes, with the prospect of high quality earnings and dividend growth. We continue to focus on income, stock selection and building a high conviction portfolio to deliver both income and capital growth. 16 July 2013
UK 100

Latest directors dealings